541 filings
Page 3 of 28
8-K
pyecyn rlzwefaooii
11 Mar 24
Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock
4:33pm
424B5
18ses5zustf1ox3flk
11 Mar 24
Prospectus supplement for primary offering
4:30pm
FWP
8pw0od9
7 Mar 24
Free writing prospectus
5:01pm
424B5
jxfewvtjhtf88hj66 p7
7 Mar 24
Prospectus supplement for primary offering
4:58pm
424B5
iyqhpt8vd0rbemh2h
7 Mar 24
Prospectus supplement for primary offering
4:25pm
8-K
rmezqbd2bkiexusakth7
7 Mar 24
Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023
8:40am
8-K
b7llexs2 zru1eegg
6 Feb 24
Amendments to Articles of Incorporation or Bylaws
9:34am
8-K
zsj6nwwx
30 Jan 24
NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
8:00am
8-K
o6ecfx47e2u41fo
26 Jan 24
Other Events
4:30pm
8-K
ody0h4dd4n7qnxja02
22 Jan 24
Other Events
8:00am
8-K
33r 0au1sgz6
16 Jan 24
Regulation FD Disclosure
8:30am
8-K
88hu8y kwo6ff
11 Jan 24
Other Events
4:59pm
8-K
vzgz4ynyvzogbcpna
8 Jan 24
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO
8:30am
8-K
rnh99a446evuyfk3
27 Dec 23
Completion of Acquisition or Disposition of Assets
4:57pm
424B5
n5wlydiwb79g
19 Dec 23
Prospectus supplement for primary offering
4:16pm
8-K
hdcwl
19 Dec 23
Other Events
4:05pm
8-K
nol anki2zb
12 Dec 23
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:03pm
8-K
fuadsjs
8 Dec 23
Entry into a Material Definitive Agreement
4:31pm
424B5
kkzllsf04 44x
8 Dec 23
Prospectus supplement for primary offering
4:24pm